Showing results (341-350 of 422) with videos related to
Sort By:
Pageof 43
Science (New York, N.Y.)|May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatmentEmma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.Scientific Reports|August 22, 2022
iPSCs derived from infertile men carrying complex genetic abnormalities can generate primordial germ-like cellsAurélie Mouka, Brahim Arkoun, Pauline Moison, et al.Journal of Asthma and Allergy|October 31, 2024
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma RegistryTham T Le, David B Price, Clement Erhard, et al.The Lancet. Respiratory Medicine|January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trialKristin B Highland, Oliver Distler, Masataka Kuwana, et al.Allergy|April 3, 2026
Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease SeverityLars I Andersson, Maciej Kupczyk, Barbro Dahlén, et al.BMJ Open Respiratory Research|July 20, 2026
Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbationsHenrik Watz, Frank C Sciurba, Matteo Bonini, et al.The European Respiratory Journal|February 16, 2022
European Respiratory Society guidelines for the diagnosis of asthma in adultsRenaud Louis, Imran Satia, Inigo Ojanguren, et al.ERJ Open Research|December 3, 2024
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort studyYoann Guirriec, David Luque-Paz, Gontran Bernard, et al.American Journal of Respiratory and Critical Care Medicine|January 13, 2009
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaSally E Wenzel, Peter J Barnes, Eugene R Bleecker, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2022
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory DiseasesG Walter Canonica, Arnaud Bourdin, Anju T Peters, et al.Pageof 43